Cooperation Agreement Concluded between BioKangtai and Biotis
- Written by PR Newswire
-- Indicating Technology Transfer of the World's First Dual-carrier 13-valent Pneumococcal Conjugate Vaccine to Indonesia
SHENZHEN, China, April 7, 2023 /PRNewswire/ -- On the morning of April 5, Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as "BioMinhai"), a wholly-owned subsidiary of Shenzhen Kangtai Biological Products...
Read more: Cooperation Agreement Concluded between BioKangtai and Biotis